# BKV Corporation (BKV) fundamentals

Data as of 2026-09-08. NYSE, United States. Sector: Energy / Oil, Gas & Consumable Fuels. Price $26.06, market value $2.9 billion.

## Valuation
- **P/E (trailing): 9.3×** (5-yr avg 13.2×, 3-yr avg 13.2×). BKV Corporation trades at 9.3× trailing earnings, well below its own five-year average of 13.2×: cheap by its own standards. The Energy median in the September 2026 study was 16.8×. Forward P/E is 14.2×, higher than trailing, so analysts expect earnings to fall.
- **PEG: 0.07**. A PEG of 0.07 means the P/E is low relative to expected earnings growth: the market is not paying much for that growth.
- **Price / sales: 2.6×**. Each dollar of revenue is priced at 2.6×.
- **Price / book: 1.2×**. The shares trade at 1.2× book value; book value is a meaningful part of the valuation.
- **EV / EBITDA: 6.4×**. Enterprise value is 6.4× operating earnings before depreciation, the multiple that ignores how the company is financed; below 8× is inexpensive for most sectors.
- **Free-cash-flow yield: -5.6%** (5-yr avg -0.7%). Free cash flow is negative: the business is consuming cash, which is normal for heavy investment phases but a warning otherwise.
- **Earnings yield: 10.7%**. The inverse of the P/E: 10.7% of the price is earned each year.

## Profitability
- **Operating margin: 35.7%**. 35.7% of revenue is left after running the business, an exceptional level.
- **Net margin: 19.4%**. 19.4% of each dollar of sales reaches the bottom line.
- **Return on equity: 8.7%**. 8.7% on shareholders' equity is weak; the business earns little on the capital its owners have in it.
- **Return on invested capital: 10.9%**. Return on all capital, debt included, is 10.9%.
- **Return on assets: 6.9%**. Each dollar of assets produces 6.9% of profit.

## Growth
- **Revenue growth (1 yr): 47.8%** (3-yr -18.7%/yr). Revenue grew 47.8% over the last year.
- **EPS growth (1 yr): 205.7%** (3-yr -32.3%/yr). Earnings per share rose 205.7%, faster than revenue, so margins expanded or the share count shrank.

## Financial health
- **Debt to equity: 0.57**. Debt is 0.57 times equity, moderate leverage.
- **Net debt / EBITDA: 1.5×**. It would take 1.5 years of operating earnings to repay net borrowings, within the comfortable range.
- **Altman Z-score: 2.03**. A Z-score of 2.03 is in the grey zone; not distressed, not clearly safe.
- **Piotroski F-score: 4/9**. 4 of 9 checks pass: mixed.

## Dividends
- **Dividend: none**. BKV Corporation does not currently pay a dividend.

## Analyst view
- **Analyst consensus: strong_buy** (11 analysts). 11 analysts cover BKV Corporation; the consensus is strong_buy, with an average price target of $34.09 (+31% from the current price). Analyst opinion is shown for context; it is not part of the Fundamental Score.

## Price and momentum
- **Total return (1 yr): 17.2%** (YTD -4.0%, 3-mo 0.4%). The shares are up 17.2% over twelve months including dividends.
- **From 52-week high: -20.6%** (29.8% above the low). Trading 21% below its 52-week high.
- **200-day average: below**. The price sits below its 200-day moving average, the usual definition of a downtrend.
- **RSI (14-day): 57**. An RSI of 57 is neutral.
- **Beta (1 yr): 0.31** (volatility 43%). Beta of 0.31 against the S&P 500: the shares move much less than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=BKV · Page: https://foliofundamentals.com/stocks/bkv

Not investment advice.